Phase III Release: Sciele/Plethora Aim To Be First To Premature Ejaculation Market
This article was originally published in The Pink Sheet Daily
Executive Summary
Firms air good Phase III data for generic combo in PE, while Vivus tackles more mature erectile dysfunction market.